SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: Andrew H who wrote (13051)1/7/1998 12:52:00 AM
From: Flagrante Delictu  Read Replies (1) | Respond to of 32384
 
Andy, >>Sounds like a post from tonyt<< Very funny. Thanks for the laugh. Of course, they mentioned Targretin for diabetes, but not in such a way as to impart anything new or anything that I thought might be nuanced. I tried to just give words or themes that I hadn't remembered noticing previously. I vaguely remember Henry thinking that they may also be trying Targretin for psoraiasis & may be waiting to see which is better. I haven't received an invitation yet to H & Q. They may be concerned about the post that I shouldn't be allowed near female soccer players that were young & beautiful. It's entirely possible that there might be a number of them invited to serve as hostesses, which may be the cause of the hold up in the receipt of my invitation.. One would think that they could truss them up in such a manner that might be sufficiently protective as to enable the risk of my attendance. Bernie.



To: Andrew H who wrote (13051)1/9/1998 2:12:00 PM
From: goro  Read Replies (2) | Respond to of 32384
 
I've only seen the summary report from RS. In it the heading was Top Picks, which mentioned LGND as one of their top biotech investment opportunities in 1998. I did not see anything about "down and out stocks that could recover in 1998" Anyway, I'm sorry for providing limited info., but RS did have a very positive comment about LGND re. outlook.